The Broad Institute, Inc.;The General Hospital Corporation;Bayer Pharma Aktiengesellschaft;President and Fellows of Harvard College;Bayer Pharma Aktiengesellschaft;拜耳醫藥股份公司;President and Fellows of Ha
发明人:
SYKES, David B.,SCADDEN, David,LEWIS, Timothy A.,JANZER, Andreas,MEYER, Hanna,STÖCKIGT, Detlef
申请号：
HK18115876
公开号：
HK1256793A1
申请日:
2018.12.11
申请国别(地区):
HK
年份:
2019
代理人:
摘要：
The present invention includes methods of treating patients with acute myeloid leukemia across a range of genetic subtypes with DHODH inhibitors, such as 6-fluoro-2-(2′-fluoro-[1,1′-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid).
